Related Experiment Videos
Anal cancers. Squamous and melanoma
1Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Cancer
|September 1, 1992
Summary
This review covers anal cancers, focusing on squamous cell carcinoma and malignant melanoma. Current chemoirradiation and surgical approaches improve survival rates for anal canal squamous cell carcinoma.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Squamous cell carcinoma and malignant melanoma are distinct types of anal cancer.
- Squamous cell carcinoma is more prevalent and requires specific management based on anatomical location (anal margin vs. anal canal).
Purpose of the Study:
- To review the experience with squamous cell carcinoma and malignant melanoma of the anus.
- To highlight the evolution of treatment strategies for anal canal squamous cell carcinoma.
- To discuss salvage options for malignant melanoma of the anus.
Main Methods:
- Retrospective review of patient cases at Memorial Sloan-Kettering Cancer Center.
- Analysis of treatment outcomes for squamous cell carcinoma and malignant melanoma.
- Comparison of historical surgical management with current chemoirradiation and surgical approaches.
Main Results:
- Squamous cell carcinoma is the more common anal cancer.
- Anatomical distinction is crucial for managing squamous cell carcinoma of the anal margin versus the anal canal.
- Current chemoirradiation followed by surgery has improved 5-year survival rates and rectal salvage for anal canal squamous cell carcinoma.
- Malignant melanoma, though rare, remains occasionally salvageable with abdominoperineal resection.
Conclusions:
- Treatment for anal squamous cell carcinoma has advanced, improving patient outcomes.
- Multimodality treatment (chemoirradiation and surgery) is effective for anal canal squamous cell carcinoma.
- Radical surgery remains a key option for rare cases of anal malignant melanoma.